ACCESS Newswire

PALO ALTO, CA / ACCESS Newswire / May 12, 2026 / Eudia, the AI platform for complex legal work, today launched a unified workspace for enterprise legal teams and the business partners they support. The unified workspace brings one standardized assistant, Eudia's suite of specialized agents (Argument Analysis, Case Analysis,...

Official launch June 16 - deposit pre-sales open May 13 across the EU HONG KONG / ACCESS Newswire / May 12, 2026 / LiberNovo today announced the Maxis Series, a new line of ergonomic chairs built for users 5'10" to 6'7" tall and weights up to 181 kg. Maxis fills a...

Elixir's new writing assistant product delivers AI-powered drafting, revision, translation, validation, tone of voice and sentiment analysis, and compliance analysis - without storing, harvesting or training on user data. OJAI, CA / ACCESS Newswire / May 12, 2026 / Elixir Technologies today introduced Elixir Muse™, a privacy-first AI writing assistant that...

Dubai Health and AGFA HealthCare have marked 20 years of collaboration supporting Dubai's healthcare system, reflecting a shared commitment to advancing integrated, patient-centered care. DUBAI, AE / ACCESS Newswire / May 12, 2026 / Over the past two decades, AGFA HealthCare has supported Dubai's healthcare system - most recently contributing to...

ZURICH, SWITZERLAND / ACCESS Newswire / May 11, 2026 / Aminona Capital Partners have successfully advised and partnered on closing a second South and Central America residential and commercial real estate fund which specifically targets large scale real estate opportunities in the region.  Co-founders Nicolas Jenik and Phillip Morelle are very...

ZURICH, SWITZERLAND / ACCESS Newswire / May 11, 2026 / Aminona Capital Partners have successfully advised and partnered on closing a second South and Central America residential and commercial real estate fund which specifically targets large scale real estate opportunities in the region.  Co-founders Nicolas Jenik and Phillip Morelle are very...

Backed by Index Ventures, Team8, and Picture Capital, Frame is launching an AI-driven platform designed to help organizations defend against the growing wave of AI-powered social engineering and deepfake attacks by empowering employees to be the strongest line of defense NEW YORK CITY, NY / ACCESS Newswire / May 11, 2026...

PHILADELPHIA, PA / ACCESS Newswire / May 8, 2026 / TruMerit, a global leader in healthcare workforce development and credential verification, today announced that it has issued its first verifiable digital credentials to healthcare professionals through a new partnership with Credivera, marking a major step forward in secure, portable credential...

World Bank and Jordan Ministry of Digital Economy-Funded Programme - Delivering the Region's First Auditable Connection Between Structured Capacity Development and Verified Income LONDON, UK / ACCESS Newswire / May 7, 2026 / Ostathi, owned and operated by UniHouse, today announced the live national deployment of a proprietary digital ledger infrastructure...

BIRKERØD, DK / ACCESS Newswire / May 7, 2026 / F1Mag® extends UMag's drone-based magnetic sensing portfolio with a high-speed, airborne system for real-time detection of naval mines and submarines in open-sea environments, covering up to 6,000 hectares per hour, without placing marine vessels and personnel at risk.  Why this matters...

From Connectivity Management to Execution. AI predicts. SIMbae enforces. RALEIGH, NC / ACCESS Newswire / May 7, 2026 /Able Device today announced a major evolution of its SIMbae™ technology, introducing AI-driven connectivity execution directly within the SIM/eSIM secure element - transforming the SIM into a deterministic enforcement engine for intelligent mobile...

How decision velocity closes the gap between insight and action in complex, fast-moving supply chains ANTWERPEN, BE / ACCESS Newswire / May 7, 2026 / OMP, a leader in AI-powered supply chain planning, brings AstraZeneca to the Gartner Supply Chain Symposium/Xpo™ 2026 in Barcelona. Together, they will share how AstraZeneca is...